- Approval Id
- beb2fd042a39dac3
- Drug Name
- LOVASTIN TABLET 20 mg
- Product Name
- LOVASTIN TABLET 20 mg
- Approval Number
- SIN12329P
- Approval Date
- 2003-06-23
- Registrant
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Licence Holder
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- **Dosage and Administration:**
The patient should be placed on a Standard cholesterol-lowering diet before receiving lovastatin and should continue on this diet during treatment with the drug. The usual starting dose is 20mg per day given as a single dose with the evening meal. Adjustment of dosage, if required, should be made at intervals of not less than 4 weeks, to a maximum of 80mg daily given in single doses or divided doses with morning and evening meals.
Concomitant therapy: Preliminary evidence suggests that the cholesterol-lowering effects of lovastatin and the bile acid sequestrant, cholestyramine, are additive.
Dosage in patients with renal insufficiency: In patient with severe renal insufficiency (creatinine clearance <30mL/min) dosage increases above 20mg/day should be carefully considered and, if deemed necessary, implemented cautiously.
To be dispensed on physician's prescription.
- Route Of Administration
- ORAL
- Indication Info
- **Indication(s):**
For the reduction of elevated total and LDL Cholesterol levels in patients with primary hypercholesterolemia) (Type IIa and IIb), when the response to diet and other nonpharmacological measures alone has been inadequate. Lovastin may be useful to reduce elevated LDL cholesterol levels in patients with combined hypercholesterolemia and hypertriglyceridemia.
Before instituting therapy with Lovastin, an attempt should be made to control hypercholesterolemia with appropriate diet, exercise, weight reduction in obese patients.
- Contraindications
- **Contraindication(s):**
1. Hypersensitivity to any component of this medication.
2. Active disease or unexplained persistent elevations of serum transaminases.
3. Pregnancy and lactation.
- Atc Code
- C10AA02
- Atc Item Name
- lovastatin
- Pharma Manufacturer Name
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/yung-shin-pharmaceutical-singapore-pte-ltd
